Dyspnoea Epistaxis Rhinitis

vomiting,

very common

vomiting

Vomiting.

Gastrointestinal adverse reactions, including nausea and vomiting, were the most common adverse reactions in patients who received active treatment, and occurred at a substantially lower rate in the Exelon 9.5 mg 24 h transdermal patch group compared to the Exelon capsule group (7.2 vs 23.1 for nausea and 6.2 vs 17.0 for vomiting 5.0 and 3.3 of patients on placebo reported nausea and vomiting, respectively).

Vomiting

Vomiting (being sick)

vomiting

throwing up (vomiting)

( 1 1,000,

Diarrhoea

1.1 1.1 1.0

Gastrointestinal adverse reactions, including nausea and vomiting, were the most common adverse reactions in patients who received active treatment, and occurred at a substantially lower rate in the Prometax 9.5 mg 24 h transdermal patch group compared to the Prometax capsule group (7.2 vs 23.1 for nausea and 6.2 vs 17.0 for vomiting 5.0 and 3.3 of patients on placebo reported nausea and vomiting, respectively).

Arthralgia

Myalgia

vomiting

Nausea

Being sick (vomiting)

vomiting,

Rash, Pruritus,

Tendonitis

Rash

Nausea Vomiting

For the prevention of vomiting including that induced by chemotherapy.

Night sweats

urticaria, pruritus, cold sweat, alopecia, hyperhidrosis arthropathy, arthralgia, back pain,

Nausea, vomiting Rash

Nausea Vomiting

Vomiting, Nausea

Diarrhoea

Diarrhoea Vomiting Dyspepsia Flatulence

Nausea, vomiting

Diarrhoea Vomiting Dyspepsia

nausea, vomiting

nausea vomiting

severe nausea

Common diarrhoea, vomiting

intercurrent illness (e. g. vomiting, diarrhoea),

Abdominal pain, diarrhoea, dry mouth, dyspepsia, flatulence Stomach upset, vomiting

Oral Candida

Abdominal pain

Dermatitis allergic

vomiting, dyspepsia